TIPS for refractory hepatic hydrothorax in patients with cirrhosis: impact of clinical response on survival.
Emergingsuggested applicable standard· AASLD, 'Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis', Hepatology 2024 (PMID 37870298) - current AASLD guidance for the portal-hypertension context in which TIPS is indicated. Procedure-specific: AASLD 'The Role of TIPS in the Management of Portal Hypertension' (Boyer & Haskal), Hepatology 2010, doi 10.1002/hep.23383.
TIPS is a percutaneous interventional-radiology procedure that creates a covered (PTFE-preferred) shunt between portal and hepatic veins to decompress portal hypertension, indicated for refractory ascites (Child-Pugh A/B, MELD <18), refractory variceal hemorrhage, EARLY/pre-emptive placement within 72 h for Child-Pugh C ≤13 (or Child-Pugh B with active bleeding) at index EGD, Budd-Chiari syndrome, and select other decompensation states. …
From our summary of this standard, unedited — the part the paper bears on. … marks omitted text. Our wording, not the guideline's; read the source for its own text.
Our full summary of this standard
TIPS is a percutaneous interventional-radiology procedure that creates a covered (PTFE-preferred) shunt between portal and hepatic veins to decompress portal hypertension, indicated for refractory ascites (Child-Pugh A/B, MELD <18), refractory variceal hemorrhage, EARLY/pre-emptive placement within 72 h for Child-Pugh C ≤13 (or Child-Pugh B with active bleeding) at index EGD, Budd-Chiari syndrome, and select other decompensation states. HVPG is measured pre/post with a target reduction ≥20% or HVPG ≤12 mmHg. All patients require pre-procedure cardiac/pulmonary/renal/LT evaluation. Post-procedure encephalopathy prophylaxis (e.g., lactulose and/or rifaximin) should be individualized based on risk factors such as prior HE, age >65, or severe liver dysfunction, with Doppler surveillance for stent dysfunction.